Virion Therapeutics
Newark, US · Founded 2018
Biotech
Founders & leadership
BR
Bernard RudnickExecutive Officer, Director
AL
Andrew LuberExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$5.7MraisedOct 2021 · 49 investors · Biotechnology
Rule 506(b)$5.2MraisedNov 2018 · 80 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.